Working… Menu

Tezosentan in the Treatment of Acute Heart Failure (VERITAS 2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00524433
Recruitment Status : Completed
First Posted : September 3, 2007
Last Update Posted : July 10, 2018
Information provided by (Responsible Party):
Idorsia Pharmaceuticals Ltd.